High circulating levels of IGF-I increase the risk of breast cancer in women from families with BRCA 1/2 mutations [53] and BRCA1 deficiency has been linked to an increase in IGF-I in both in vitro and in vivo models [22, 30]. Here, BRCA1 is linked to breast carcinoma.